沪深市场个股详情
300813 泰林生物
- 23.75
- +0.41+1.76%
已收盘 11/11 15:00 (北京)
25.92亿总市值266.85市盈率TTM
23.78最高价23.00最低价2.93万手成交量23.30今开23.34昨收6844.07万成交额5.07%换手率131.94市盈率(静)1.09亿总股本29.8052周最高4.41市净率13.70亿流通值10.9152周最低28.01涨停价5768.69万流通股66.50历史最高18.67跌停价3.34%振幅10.78历史最低0.10股息TTM23.38平均价1.47万手内盘0.42%股息率TTM100股每手1.40万手外盘
泰林生物关键统计数据
全部
显示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 19.37%2.42亿 | 9.68%1.56亿 | 1.34%8,000.66万 | -27.82%2.7亿 | -13.09%2.03亿 | -2.21%1.42亿 | 10.36%7,894.66万 | 32.00%3.74亿 | 28.09%2.34亿 | 31.22%1.46亿 |
| 营业收入 | 19.37%2.42亿 | 9.68%1.56亿 | 1.34%8,000.66万 | -27.82%2.7亿 | -13.09%2.03亿 | -2.21%1.42亿 | 10.36%7,894.66万 | 32.00%3.74亿 | 28.09%2.34亿 | 31.22%1.46亿 |
| 其他业务收入 | ---- | 4.77%1,642万 | ---- | 16.13%3,353.52万 | ---- | 18.19%1,567.29万 | ---- | -2.48%2,887.84万 | ---- | 9.88%1,326.04万 |
| 营业总成本 | 22.20%2.36亿 | 21.20%1.52亿 | 19.09%7,731.82万 | -15.42%2.64亿 | 0.08%1.93亿 | 6.05%1.25亿 | 14.64%6,492.44万 | 39.18%3.12亿 | 39.65%1.93亿 | 43.83%1.18亿 |
| 营业成本 | 35.23%1.26亿 | 27.76%8,106.61万 | 16.89%4,409.03万 | -23.46%1.36亿 | -9.48%9,339.41万 | 3.49%6,345.04万 | 21.64%3,771.83万 | 64.17%1.77亿 | 52.40%1.03亿 | 54.16%6,131.04万 |
| 营业税金及附加 | 21.41%258.39万 | 19.45%174.7万 | 48.62%110.66万 | 15.88%389.39万 | 30.07%212.82万 | 35.12%146.26万 | 34.71%74.46万 | -13.59%336.02万 | -35.26%163.62万 | -38.27%108.24万 |
| 销售费用 | 3.38%3,170.91万 | 13.75%2,022.47万 | 23.37%910.91万 | 4.94%4,503.81万 | 12.75%3,067.25万 | 8.16%1,778.04万 | -5.56%738.34万 | 9.65%4,291.73万 | 23.17%2,720.33万 | 25.28%1,643.86万 |
| 管理费用 | -14.02%2,281.78万 | -5.06%1,594.65万 | -7.93%745.59万 | -3.93%3,177.7万 | 17.12%2,653.85万 | 14.99%1,679.66万 | 30.19%809.84万 | 33.39%3,307.69万 | 34.57%2,265.84万 | 24.71%1,460.65万 |
| 财务费用 | 144.47%336.12万 | 137.60%175.2万 | 122.25%65.98万 | -20.57%-1,078.9万 | -14.99%-755.91万 | -11.37%-465.97万 | -11.12%-296.58万 | -35.99%-894.83万 | 5.10%-657.34万 | 28.56%-418.41万 |
| -利息费用 | 3,005.71%1,154.54万 | 4,091.03%767.98万 | ---- | -33.44%58.68万 | -21.71%37.17万 | --18.32万 | --9,908.47 | 566.99%88.17万 | --47.48万 | ---- |
| -利息收入 | -8.14%-849.58万 | -19.03%-593.35万 | -1.93%-314.02万 | -12.05%-1,110.86万 | -10.72%-785.63万 | -13.36%-498.49万 | -11.91%-308.09万 | -46.64%-991.39万 | -2.42%-709.59万 | 24.60%-439.72万 |
| 研发费用 | 2.75%4,945.44万 | 2.23%3,125.21万 | 6.82%1,489.64万 | -9.41%5,840.38万 | 6.85%4,812.91万 | 5.45%3,057.15万 | 1.78%1,394.54万 | 17.11%6,446.77万 | 24.85%4,504.33万 | 33.55%2,899.14万 |
| 信用减值损失 | -4,081.29%-42.12万 | -382.60%-85.67万 | -39.49%-24.61万 | -190.78%-128.82万 | -99.02%1.06万 | -77.32%30.32万 | 45.45%-17.64万 | 175.10%141.9万 | 171.07%108.42万 | 195.41%133.69万 |
| 资产减值损失 | -24.78%-20.5万 | -68.97%-21.32万 | ---- | 81.48%-12.27万 | -1,043.98%-16.43万 | 35.94%-12.62万 | ---- | 26.17%-66.22万 | 96.67%-1.44万 | 51.98%-19.69万 |
| 非经营性净收益 | -48.71%660.53万 | -55.48%316.09万 | -21.98%315.13万 | -10.91%1,592.83万 | 44.16%1,287.92万 | 19.89%709.98万 | 4,025.81%403.92万 | 65.27%1,787.89万 | 225.80%893.41万 | 205.01%592.21万 |
| 投资净收益 | ---- | ---7.19万 | ---- | -103.24%-1.17万 | ---- | ---- | ---- | -85.23%36.07万 | --27.19万 | --27.19万 |
| 资产处置收益 | ---- | ---- | ---- | -108.97%-2,158.2 | -104.28%-2,158.2 | -104.28%-2,158.2 | ---2,158.2 | --2.41万 | --5.04万 | --5.04万 |
| 其他收益 | -44.52%723.15万 | -37.87%430.27万 | -19.45%339.74万 | 3.68%1,735.3万 | 72.83%1,303.51万 | 55.27%692.5万 | 3,905.84%421.77万 | 50.60%1,673.73万 | 60.49%754.2万 | 18.84%445.98万 |
| 营业利润 | -43.37%1,285.08万 | -69.18%745.45万 | -67.67%583.98万 | -72.64%2,177.85万 | -54.16%2,269.36万 | -27.54%2,418.44万 | 22.04%1,806.13万 | 14.07%7,961.26万 | 5.56%4,950.81万 | 8.47%3,337.68万 |
| 加:营业外收入 | -50.09%40.27万 | -45.60%34.4万 | -13.76%8.51万 | -46.84%76.91万 | 687.91%80.68万 | 856.51%63.23万 | 6.62%9.87万 | 2,256.44%144.66万 | 112.10%10.24万 | 42.74%6.61万 |
| 减:营业外支出 | 5.86%65.82万 | 1,459.41%58.96万 | -77.39%9,106 | -48.58%57.17万 | 3,059.61%62.18万 | 1,591.58%3.78万 | 2,531.22%4.03万 | 427.25%111.19万 | -73.03%1.97万 | -96.45%2,235.18 |
| 利润总额 | -44.95%1,259.53万 | -70.91%720.89万 | -67.35%591.58万 | -72.51%2,197.59万 | -53.87%2,287.86万 | -25.90%2,477.89万 | 21.69%1,811.97万 | 14.79%7,994.73万 | 5.80%4,959.08万 | 8.74%3,344.07万 |
| 减:所得税费用 | -5.56%199.54万 | -24.24%134.27万 | -31.23%37.46万 | 1,252.21%353.07万 | -9.35%211.29万 | -17.26%177.23万 | -43.57%54.47万 | -95.73%26.11万 | -48.19%233.08万 | -30.88%214.19万 |
| 净利润 | -48.95%1,059.99万 | -74.50%586.62万 | -68.47%554.12万 | -76.85%1,844.52万 | -56.06%2,076.57万 | -26.49%2,300.66万 | 26.21%1,757.5万 | 25.43%7,968.62万 | 11.53%4,726万 | 13.18%3,129.88万 |
| 持续经营净利润 | -48.95%1,059.99万 | -74.50%586.62万 | -68.47%554.12万 | -76.85%1,844.52万 | -56.06%2,076.57万 | -26.49%2,300.66万 | 26.21%1,757.5万 | 25.43%7,968.62万 | 11.53%4,726万 | 13.18%3,129.88万 |
| 减：少数股东损益 | -30.85%-71.48万 | -281.98%-71.59万 | ---33.19万 | ---122.38万 | ---54.63万 | ---18.74万 | ---- | ---- | ---- | ---- |
| 归属于母公司所有者的净利润 | -46.91%1,131.47万 | -71.62%658.21万 | -66.58%587.31万 | -75.32%1,966.9万 | -54.90%2,131.2万 | -25.89%2,319.4万 | 26.21%1,757.5万 | 25.43%7,968.62万 | 11.53%4,726万 | 13.18%3,129.88万 |
| 每股收益 | ||||||||||
| 基本每股收益 | -50.00%0.1 | -71.43%0.06 | -76.19%0.05 | -75.68%0.18 | -64.91%0.2 | -27.59%0.21 | -22.22%0.21 | -2.63%0.74 | -30.49%0.57 | -12.12%0.29 |
| 稀释每股收益 | -26.32%0.14 | -50.00%0.1 | -75.00%0.05 | -76.06%0.17 | -65.45%0.19 | -28.57%0.2 | -25.93%0.2 | -6.58%0.71 | -32.93%0.55 | -15.15%0.28 |
| 其他综合收益 | ||||||||||
| 综合收益总额 | -48.95%1,059.99万 | -74.50%586.62万 | -68.47%554.12万 | -76.85%1,844.52万 | -56.06%2,076.57万 | -26.49%2,300.66万 | 26.21%1,757.5万 | 25.43%7,968.62万 | 11.53%4,726万 | 13.18%3,129.88万 |
| 归属于母公司所有者的综合收益总额 | -46.91%1,131.47万 | -71.62%658.21万 | -66.58%587.31万 | -75.32%1,966.9万 | -54.90%2,131.2万 | -25.89%2,319.4万 | 26.21%1,757.5万 | 25.43%7,968.62万 | 11.53%4,726万 | 13.18%3,129.88万 |
| 归属于少数股东的综合收益总额 | -30.85%-71.48万 | -281.98%-71.59万 | ---33.19万 | ---122.38万 | ---54.63万 | ---18.74万 | ---- | ---- | ---- | ---- |
| 货币单位 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
| 会计准则 | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) | 新会计准则(2007) |
| 审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | 无保留意见 | -- | -- |
| 会计师事务所 | -- | -- | -- | 天健会计师事务所(特殊普通合伙) | -- | -- | -- | 天健会计师事务所(特殊普通合伙) | -- | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。
分析
目标价预测
暂无数据
热议
沪深
综合热度
股票代码
最新价
涨跌幅
暂无数据